Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1995-01-13
1996-10-01
Ivy, C. Warren
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
546241, A61K 31445
Patent
active
055611443
ABSTRACT:
The present invention is directed to a new 5HT.sub.2 antagonist, (+)-.alpha.-(2,3-dimethoxyphenyl)-1-[2-(4-fluorophenyl)ethyl]-4-piperidine methanol, and its use in the treatment of a number of disease states.
REFERENCES:
patent: 4762842 (1988-08-01), Cohen
patent: 5112978 (1992-05-01), Molinari
patent: 5169096 (1992-12-01), Carr
Ugedo, Chemical Abstracts 111:17563, 1989.
Pharmacology and Toxicology Supplement 1, 1990, 5-7, E. Christensson et al.
Pharmacology and Toxicology Supplement 1, 1990, 12-17, B. Gustaffson et al.
Life Sciences, vol. 47, pp. 2401-2408, J. Frank Nash, 1990.
The Journal of Pharmacology and Experimental Therapeutics, vol. 253, No. 3, 1162-1170, 1990.
Journal of Neurochemistry, vol. 54, No. 3, 1990, 1062-1066, Nash et al.
The Journal of Pharmacology and Experimental Therapeutics, vol. 249, No. 3, 673-679, Goldstein et al., 1989.
Psychopharmacology (1989) vol. 99:S18-S27;H. Y. Meltzer.
The Journal of Pharmacology and Experimental Therapeutics, vol. 251:238-246, Meltzer et al., 1989.
4-Aroylpiperidines and Related Carbinols as Potent and Selective Inhibitors of Serotonin 5-HT2 Receptors with Antipsychotic Potential, Abstract of presentation at International Congress on Schizophrenic Research present in Tuscon Arizona on Apr. 21-25, 1991.
an electrophysiological investigation of the mechanism of action of the mechanism of action of the 5-ht2 antagonists ritanserin and mdl 28,133a on amphetamine induced slowing of a10 dopamine neurons, Abstract of presentation at International Congress on Schizophrenic Research present in Tuscon Arizona on Apr. 21-25, 1991.
Psychopharmacology (1989) 98:45-50: L. Ugedo et al.
Drugs of the Future vol. 14, No. 5, 1989, pp. 489-490.
Carr Albert A.
Hay David A.
Kane John M.
Schmidt Christopher J.
Ivy C. Warren
M. Mach D. Margaret
Merrell Pharmaceuticals Inc.
Moon Carolyn D.
LandOfFree
(+)-.alpha.-(2,3-dime thoxyphenyl)-1-[2-(4-fluorophenyl)ethyl]-4 does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with (+)-.alpha.-(2,3-dime thoxyphenyl)-1-[2-(4-fluorophenyl)ethyl]-4, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and (+)-.alpha.-(2,3-dime thoxyphenyl)-1-[2-(4-fluorophenyl)ethyl]-4 will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1502162